Reports

Ideas That Generate Results

US Non-Invasive Prenatal Diagnostics - Market Insight

US Non-Invasive Prenatal Diagnostics - Market Insight

Format :  Adobe Reader (PDF) Upto 24 hour delivery
Publish Date : Jun, 2013| No. of Pages : 60

Share |
 
Please make your selection :
Electronic Access - Single User License
US$ 1200.00
CD-ROM Mail Delivery
US$ 1500.00
Hard Copy Mail Delivery
US$ 1500.00
Electronic Access - Multi-User License
US$ 2000.00

List of Figures:

Figure 3-1: Population Base (Million), 2000-2010
Figure 4-1: Prenatal Testing Market (Billion US$), 2012-2016
Figure 4-2: Preliminary Prenatal Testing Market (Million US$), 2012-2016
Figure 4-3: First Trimester Screening Market (Million US$), 2012-2016
Figure 4-4: Second Trimester Screening Market (Million US$), 2012-2016
Figure 4-5: CVS Testing Market (Million US$), 2012-2016
Figure 4-6: Amniocentesis Testing Market (Million US$), 2012-2016
Figure 5-1: Non-Invasive Prenatal Diagnostics Market (Million US$), 2012-2017
Figure 5-2: Share of Players in Number of NIPD Tests Performed (2012)
Figure 5-3: Share of Players in NIPD Market (2012)
Figure 5-4: Forecast for Share of Players in Number of NIPD Tests Performed (2017)
Figure 5-5: Forecast for Share of Players in NIPD Market (2017)
Figure 5-6: Laboratorians’ Attitudes towards FDAs Regulations on Lab Developed Tests (LDT)

List of Tables:

Table 3-1: Number of Births and Abortions (2000-2010)
Table 3-2: Number of Multiple Pregnancies (2000-2009)
Table 3-3: Prevalence of Chromosomal Abnormalities
Table 4-1: Major Preliminary Prenatal Tests Performed
Table 4-2: Major First Trimester Screening Tests Performed
Table 4-3: Major Second Trimester Screening Tests Performed
Table 5-1: Inter-comparison of CLIA and FDA Regulatory Pathway
Table 6-1: Common Commercial Kits and Protocols for Isolation of ccff DNA from Maternal Plasma

Not able to find data you are looking for? Ask our Research Analyst.

media citation

get in touch

Please fill-in the information below.